Shared care prescribing for ADHD medication—benefits prevail and risks can be managed

Abstract

Salisbury discusses the challenges of attention deficit/hyperactivity disorder (ADHD) care in the UK, particularly the strain on NHS services and the complexities of shared care prescribing.1 The rise in ADHD diagnoses has exposed systemic inadequacies, leading to long waiting times and inconsistent care pathways.2 Concerns about overmedication and misdiagnosis are valid and merit attention, as do issues around shared care prescribing.3 But the discussion would benefit from a broader perspective that reflects the diverse experiences of …